VOTE QUESTION: On Motion to Concur in the Senate Amendment, DESCRIPTION: One Big Beautiful Bill Act, VOTE TYPE: Recorded Vote, STATUS: Passed

After de-emphasizing heart surgery for decades due to limits with its earlier platforms, the surgical robot maker is eyeing the large market in cardiovascular disease treatment.

After de-emphasizing heart surgery for decades due to limits with its earlier platforms, the surgical robot maker is eyeing the large market in cardiovascular disease treatment.

The smart ring maker is filing to go public as wearables firms work to incorporate more health features into their devices.

Barghout, who led Recor when it won FDA approval of the first renal denervation treatment for hypertension, is the new president of Medtronic's Interventional Cardiology Therapies business.

Barghout, who led Recor when it won FDA approval of the first renal denervation treatment for hypertension, is the new president of Medtronic's Interventional Cardiology Therapies business.